Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Oxidative free radicals refer to a broad family of atoms or molecules characterized by the presence of one or more unpaired electrons, rendering them highly reactive and short-lived. The main biological subtypes include reactive oxygen species (such as superoxide anion, hydroxyl radical, and hydrogen peroxide) and reactive nitrogen species (such as nitric oxide and peroxynitrite). Their formation is a consequence of both physiological metabolic processes (mitochondrial respiration, immune cell activation, enzymatic reactions) and environmental factors (UV radiation, pollution, smoking). While essential for certain cellular signaling pathways and immune responses, uncontrolled production or inadequate detoxification of free radicals leads to oxidative stress, causing cumulative damage to DNA, proteins, and lipids. This oxidative damage plays a key role in the pathogenesis of diverse chronic diseases, including cancer, cardiovascular disease, chronic inflammation, neurodegenerative disorders, and contributes to aging. Therapeutic efforts typically focus on modulating the balance between free radical production and antioxidant defense, but the non-specific and ubiquitous nature of free radicals makes them an unsuitable conventional drug target, as opposed to distinct proteins or receptors[1][3][5][7]. Because "oxidative free radicals" are not a single molecular target but a heterogeneous group of highly reactive species, this entry does not represent a canonical drug target, and the term is scientifically imprecise for structured target databases.
Free radical scavenging (antioxidants donate electrons to neutralize radicals); Enhancement of endogenous antioxidant enzymes (e.g., upregulation of SOD, catalase, and glutathione peroxidase); Metal chelation (prevents metal-catalyzed radical formation); Inhibition of ROS-producing enzymes (e.g., xanthine oxidase inhibitors)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oxidative Free Radicals.